FDA Inspection
Regenerative Biologics, Inc.FDA Inspection 826054 - Regenerative Biologics, Inc. - April 08, 2013
Record Details
This FDA Inspection record concerns Regenerative Biologics, Inc., with an inspection on April 8, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
Open in Dashboard
ID · db2217ed-4cef-4d3d-bff5-5934809df35a
Violation Codes2
21 CFR 1271.180(a)21 CFR 1271.260(e)
Full citation text and observation details available on the Dashboard.